Publications & News

We discover and harness key health-boosting microbes using advanced microbiome expertise to drive better disease prevention and treatment.

NewsApril 22, 2026

Ostia Sciences accelerates growth with new $12 million expansion in Ontario

PublicationsApril 22, 2026

Phosphorylated lantibiotics-producing commensals integrate into the human oral microbiome to suppress pathogens and promote microbiome homeostasis

PublicationsDecember 22, 2025

Comprehensive safety assessment of the probiotic Streptococcus salivarius OSTIA SALI-10

NewsSeptember 22, 2025

What If Oral Care Could Be Smarter?

NewsJuly 18, 2025

Ostia Sciences Inc. Completes $1.46M Seed Round to Develop Microbiome Therapeutics Platform

PublicationsJuly 8, 2025

Prognostic utility of oral neutrophil counts in high-risk periodontitis: A retrospective study

NewsMay 26, 2025

Ostia Sciences and EXPERT’Biome CDMO By Lallemand Celebrate A Major Milestone for Producing a New Oral Care Probiotic

PublicationsOctober 1, 2024

Ostia Sciences Inc. Secures Over $1 Million CAD in Seed Investment Round

NewsOctober 22, 2023

U of T start-up’s breakthrough molecule: Eliminating pathogens without harming oral microbiota

PublicationsApril 16, 2023

Discovery of phosphorylated lantibiotics with proimmune activity that regulate the oral microbiome

PublicationsJuly 13, 2022

The Effect of Intensity-Modulated Radiotherapy to the Head and Neck Region on the Oral Innate Immune Response and Oral Microbiome: A Prospective Cohort Study of Head and Neck Tumour Patients

NewsPublicationsJuly 6, 2021

Metabolites of the oral microbiome: important mediators of multikingdom interactions

PublicationsOctober 20, 2020

Periodontal Inflammation Primes the Systemic Innate Immune Response

PublicationsJuly 21, 2020

Evolution of Lantibiotic Salivaricins: New Weapons to Fight Infectious Diseases

NewsAugust 16, 2016

New insights into the mode of action of the lantibiotic salivaricin B

PublicationsSeptember 21, 2011

Publications & News